Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-011566
Date:2023-02-17
Issuer: KINNATE BIOPHARMA INC. (KNTE)
Original Submission Date:

Reporting Person:

TANANBAUM JAMES B.
900 LARKSPUR LANDING CIRCLE
SUITE 150 LARKSPUR, CA 94939

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-02-17 J 1,100,000 a $0.00 1,975,001 indirect
COMMON STOCK 2023-02-17 0 $0.00 9,671,643 indirect
COMMON STOCK 2023-02-17 0 $0.00 291,667 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 on february 17, 2023, the issuer completed the acquisition of kinnjiu biompharma, inc. (the "kinnjiu acquisition"). foresite capital fund v, l.p. ("fund v") was a shareholder of kinnjiu biompharma, inc. and, as a result of the kinnjiu acquisition, fund v received a combination of cash and 1,100,000 shares of the issuer's common stock.
f2 received in exchange for 17,500,000 shares of kinnjiu biopharma, inc. in connection with the kinnjiu acquisition. the number of shares received was determined based on a volume weighted average price per share of $6.7757.
f3 the shares are owned directly by fund v. foresite capital management v, llc ("fcm v") is the general partner of fund v and may be deemed to have sole voting and dispositive power over these shares. the reporting person ("dr. tananbaum") is the sole managing member of fcm v and may be deemed to have sole voting and dispositive power over these shares. dr. tananbaum disclaims the existence of a "group." each of fcm v and dr. tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that fcm v or dr. tananbaum is the beneficial owner of these shares for purposes of section 16 or any other purpose.
f4 the shares are owned directly by foresite capital fund iv, l.p. ("fund iv"). foresite capital management iv, llc ("fcm iv") is the general partner of fund iv and may be deemed to have sole voting and dispositive power over these shares. dr. tananbaum is the sole managing member of fcm iv and may be deemed to have sole voting and dispositive power over these shares. dr. tananbaum disclaims the existence of a "group." each of fcm iv and dr. tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that fcm iv or dr. tananbaum is the beneficial owner of these shares for purposes of section 16 or any other purpose.
f5 the shares are owned directly by foresite capital opportunity fund v, l.p. ("opportunity fund v"). foresite capital opportunity management v, llc ("fcom v") is the general partner of opportunity fund v and may be deemed to have sole voting and dispositive power over these shares. dr. tananbaum is the sole managing member of fcom v and may be deemed to have sole voting and dispositive power over these shares. dr. tananbaum disclaims the existence of a "group." each of fcom v and dr. tananbaum disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that fcom v or dr. tananbaum is the beneficial owner of these shares for purposes of section 16 or any other purpose.
WhaleWisdom Logo

Elevate your investments